Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
Go back to Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome| NEWMARKET CORPORATION (NYSE: NEU) | Delayed: 909.15 +6.03 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $903.12 | 52 Week High | $447.97 | |||
| Open | $899.88 | 52 Week Low | $322.54 | |||
| Day High | $916.17 | P/E | 49.93 | |||
| Day Low | $899.88 | EPS | $18.21 | |||
| Volume | 128,530 | |||||
